nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—ABCC10—Gemcitabine—urinary bladder cancer	0.0614	0.102	CbGbCtD
Cyclosporine—ABCC10—Etoposide—urinary bladder cancer	0.0438	0.0732	CbGbCtD
Cyclosporine—ABCC3—Fluorouracil—urinary bladder cancer	0.033	0.0551	CbGbCtD
Cyclosporine—ABCC10—Doxorubicin—urinary bladder cancer	0.0299	0.0499	CbGbCtD
Cyclosporine—ABCC10—Methotrexate—urinary bladder cancer	0.0289	0.0483	CbGbCtD
Cyclosporine—ABCC3—Cisplatin—urinary bladder cancer	0.028	0.0468	CbGbCtD
Cyclosporine—ABCC3—Etoposide—urinary bladder cancer	0.0275	0.046	CbGbCtD
Cyclosporine—ABCC1—Epirubicin—urinary bladder cancer	0.0217	0.0363	CbGbCtD
Cyclosporine—ABCB1—Mitomycin—urinary bladder cancer	0.0199	0.0332	CbGbCtD
Cyclosporine—ABCC3—Doxorubicin—urinary bladder cancer	0.0188	0.0314	CbGbCtD
Cyclosporine—ABCC3—Methotrexate—urinary bladder cancer	0.0182	0.0304	CbGbCtD
Cyclosporine—ABCC1—Etoposide—urinary bladder cancer	0.0169	0.0283	CbGbCtD
Cyclosporine—ABCB11—Doxorubicin—urinary bladder cancer	0.0162	0.0271	CbGbCtD
Cyclosporine—ABCC2—Carboplatin—urinary bladder cancer	0.0149	0.0249	CbGbCtD
Cyclosporine—ABCG2—Fluorouracil—urinary bladder cancer	0.0136	0.0227	CbGbCtD
Cyclosporine—ABCG2—Carboplatin—urinary bladder cancer	0.0135	0.0225	CbGbCtD
Cyclosporine—ABCC2—Cisplatin—urinary bladder cancer	0.0127	0.0213	CbGbCtD
Cyclosporine—ABCC2—Etoposide—urinary bladder cancer	0.0125	0.0209	CbGbCtD
Cyclosporine—ABCC1—Doxorubicin—urinary bladder cancer	0.0115	0.0193	CbGbCtD
Cyclosporine—ABCG2—Cisplatin—urinary bladder cancer	0.0115	0.0192	CbGbCtD
Cyclosporine—ABCG2—Etoposide—urinary bladder cancer	0.0113	0.0189	CbGbCtD
Cyclosporine—ABCC1—Methotrexate—urinary bladder cancer	0.0112	0.0187	CbGbCtD
Cyclosporine—SLCO1A2—Methotrexate—urinary bladder cancer	0.00998	0.0167	CbGbCtD
Cyclosporine—SLCO1B1—Methotrexate—urinary bladder cancer	0.00941	0.0157	CbGbCtD
Cyclosporine—CYP3A4—Thiotepa—urinary bladder cancer	0.00902	0.0151	CbGbCtD
Cyclosporine—ABCC2—Doxorubicin—urinary bladder cancer	0.00854	0.0143	CbGbCtD
Cyclosporine—ABCC2—Methotrexate—urinary bladder cancer	0.00827	0.0138	CbGbCtD
Cyclosporine—ABCG2—Doxorubicin—urinary bladder cancer	0.00772	0.0129	CbGbCtD
Cyclosporine—ABCG2—Methotrexate—urinary bladder cancer	0.00748	0.0125	CbGbCtD
Cyclosporine—CYP2C8—Fluorouracil—urinary bladder cancer	0.00722	0.0121	CbGbCtD
Cyclosporine—CYP3A5—Etoposide—urinary bladder cancer	0.00627	0.0105	CbGbCtD
Cyclosporine—SLC22A6—Methotrexate—urinary bladder cancer	0.00605	0.0101	CbGbCtD
Cyclosporine—CYP2C8—Etoposide—urinary bladder cancer	0.00603	0.0101	CbGbCtD
Cyclosporine—ABCB1—Gemcitabine—urinary bladder cancer	0.00572	0.00955	CbGbCtD
Cyclosporine—CYP2C9—Fluorouracil—urinary bladder cancer	0.00504	0.00842	CbGbCtD
Cyclosporine—CYP2C9—Cisplatin—urinary bladder cancer	0.00428	0.00715	CbGbCtD
Cyclosporine—ABCB1—Cisplatin—urinary bladder cancer	0.00415	0.00694	CbGbCtD
Cyclosporine—ABCB1—Etoposide—urinary bladder cancer	0.00408	0.00682	CbGbCtD
Cyclosporine—FKBP1B—prostate gland—urinary bladder cancer	0.0035	0.0363	CbGeAlD
Cyclosporine—PPP3R2—female reproductive system—urinary bladder cancer	0.00332	0.0345	CbGeAlD
Cyclosporine—ABCB1—Doxorubicin—urinary bladder cancer	0.00278	0.00465	CbGbCtD
Cyclosporine—ABCB1—Methotrexate—urinary bladder cancer	0.0027	0.0045	CbGbCtD
Cyclosporine—CYP2D6—Doxorubicin—urinary bladder cancer	0.00262	0.00438	CbGbCtD
Cyclosporine—CYP3A4—Etoposide—urinary bladder cancer	0.00245	0.00408	CbGbCtD
Cyclosporine—FKBP4—prostate gland—urinary bladder cancer	0.00231	0.024	CbGeAlD
Cyclosporine—PPID—prostate gland—urinary bladder cancer	0.00213	0.0222	CbGeAlD
Cyclosporine—CAMLG—prostate gland—urinary bladder cancer	0.0021	0.0219	CbGeAlD
Cyclosporine—PPIA—prostate gland—urinary bladder cancer	0.00192	0.0199	CbGeAlD
Cyclosporine—PPID—seminal vesicle—urinary bladder cancer	0.0018	0.0188	CbGeAlD
Cyclosporine—CAMLG—seminal vesicle—urinary bladder cancer	0.00178	0.0185	CbGeAlD
Cyclosporine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00167	0.00279	CbGbCtD
Cyclosporine—SLC10A2—renal system—urinary bladder cancer	0.00159	0.0165	CbGeAlD
Cyclosporine—FKBP4—renal system—urinary bladder cancer	0.00158	0.0164	CbGeAlD
Cyclosporine—PPIF—prostate gland—urinary bladder cancer	0.00155	0.0161	CbGeAlD
Cyclosporine—CYP2C19—urine—urinary bladder cancer	0.00152	0.0158	CbGeAlD
Cyclosporine—PPID—smooth muscle tissue—urinary bladder cancer	0.00151	0.0157	CbGeAlD
Cyclosporine—PPP3CA—prostate gland—urinary bladder cancer	0.00149	0.0154	CbGeAlD
Cyclosporine—PPIB—prostate gland—urinary bladder cancer	0.00148	0.0154	CbGeAlD
Cyclosporine—PPID—renal system—urinary bladder cancer	0.00145	0.0151	CbGeAlD
Cyclosporine—PPID—urethra—urinary bladder cancer	0.00143	0.0149	CbGeAlD
Cyclosporine—CAMLG—urethra—urinary bladder cancer	0.00141	0.0146	CbGeAlD
Cyclosporine—PPIF—seminal vesicle—urinary bladder cancer	0.00131	0.0136	CbGeAlD
Cyclosporine—PPIA—urethra—urinary bladder cancer	0.00128	0.0133	CbGeAlD
Cyclosporine—SLC10A1—prostate gland—urinary bladder cancer	0.00126	0.0131	CbGeAlD
Cyclosporine—FKBP4—female reproductive system—urinary bladder cancer	0.00126	0.0131	CbGeAlD
Cyclosporine—PPP3CA—seminal vesicle—urinary bladder cancer	0.00126	0.0131	CbGeAlD
Cyclosporine—PPIB—seminal vesicle—urinary bladder cancer	0.00125	0.013	CbGeAlD
Cyclosporine—CYP2C9—urine—urinary bladder cancer	0.00118	0.0122	CbGeAlD
Cyclosporine—PPID—female reproductive system—urinary bladder cancer	0.00116	0.0121	CbGeAlD
Cyclosporine—SLC10A2—vagina—urinary bladder cancer	0.00115	0.012	CbGeAlD
Cyclosporine—CAMLG—female reproductive system—urinary bladder cancer	0.00115	0.0119	CbGeAlD
Cyclosporine—FKBP1B—lymph node—urinary bladder cancer	0.00112	0.0116	CbGeAlD
Cyclosporine—PPIF—smooth muscle tissue—urinary bladder cancer	0.0011	0.0114	CbGeAlD
Cyclosporine—PPIB—epithelium—urinary bladder cancer	0.00108	0.0113	CbGeAlD
Cyclosporine—SLC10A1—seminal vesicle—urinary bladder cancer	0.00107	0.0111	CbGeAlD
Cyclosporine—PPIF—renal system—urinary bladder cancer	0.00106	0.011	CbGeAlD
Cyclosporine—PPID—vagina—urinary bladder cancer	0.00105	0.011	CbGeAlD
Cyclosporine—PPP3CA—smooth muscle tissue—urinary bladder cancer	0.00105	0.0109	CbGeAlD
Cyclosporine—PPIB—smooth muscle tissue—urinary bladder cancer	0.00105	0.0109	CbGeAlD
Cyclosporine—PPIF—urethra—urinary bladder cancer	0.00104	0.0108	CbGeAlD
Cyclosporine—CAMLG—vagina—urinary bladder cancer	0.00104	0.0108	CbGeAlD
Cyclosporine—PPP3CA—renal system—urinary bladder cancer	0.00101	0.0105	CbGeAlD
Cyclosporine—PPIB—renal system—urinary bladder cancer	0.00101	0.0105	CbGeAlD
Cyclosporine—PPP3CA—urethra—urinary bladder cancer	0.000994	0.0103	CbGeAlD
Cyclosporine—PPIB—urethra—urinary bladder cancer	0.000989	0.0103	CbGeAlD
Cyclosporine—FKBP1A—prostate gland—urinary bladder cancer	0.000987	0.0103	CbGeAlD
Cyclosporine—PPIA—vagina—urinary bladder cancer	0.000946	0.00983	CbGeAlD
Cyclosporine—CYP3A4—urine—urinary bladder cancer	0.000898	0.00934	CbGeAlD
Cyclosporine—CYP2D6—urine—urinary bladder cancer	0.000884	0.00919	CbGeAlD
Cyclosporine—SLC10A1—renal system—urinary bladder cancer	0.000861	0.00895	CbGeAlD
Cyclosporine—PPIF—female reproductive system—urinary bladder cancer	0.000847	0.0088	CbGeAlD
Cyclosporine—FKBP1A—seminal vesicle—urinary bladder cancer	0.000835	0.00868	CbGeAlD
Cyclosporine—PPP3CA—female reproductive system—urinary bladder cancer	0.000811	0.00843	CbGeAlD
Cyclosporine—PPIB—female reproductive system—urinary bladder cancer	0.000806	0.00838	CbGeAlD
Cyclosporine—ABCC3—prostate gland—urinary bladder cancer	0.000794	0.00826	CbGeAlD
Cyclosporine—ABCC10—prostate gland—urinary bladder cancer	0.00079	0.00822	CbGeAlD
Cyclosporine—PPIF—vagina—urinary bladder cancer	0.000766	0.00796	CbGeAlD
Cyclosporine—FKBP4—lymph node—urinary bladder cancer	0.000738	0.00767	CbGeAlD
Cyclosporine—PPP3CA—vagina—urinary bladder cancer	0.000733	0.00762	CbGeAlD
Cyclosporine—PPIB—vagina—urinary bladder cancer	0.000729	0.00758	CbGeAlD
Cyclosporine—FKBP1A—epithelium—urinary bladder cancer	0.000725	0.00754	CbGeAlD
Cyclosporine—FKBP1A—smooth muscle tissue—urinary bladder cancer	0.000699	0.00726	CbGeAlD
Cyclosporine—SLC10A1—female reproductive system—urinary bladder cancer	0.000689	0.00717	CbGeAlD
Cyclosporine—PPID—lymph node—urinary bladder cancer	0.000681	0.00708	CbGeAlD
Cyclosporine—FKBP1A—renal system—urinary bladder cancer	0.000673	0.00699	CbGeAlD
Cyclosporine—CAMLG—lymph node—urinary bladder cancer	0.000672	0.00698	CbGeAlD
Cyclosporine—ABCC10—seminal vesicle—urinary bladder cancer	0.000669	0.00695	CbGeAlD
Cyclosporine—FKBP1A—urethra—urinary bladder cancer	0.000661	0.00687	CbGeAlD
Cyclosporine—ABCC2—prostate gland—urinary bladder cancer	0.000635	0.0066	CbGeAlD
Cyclosporine—PPIA—lymph node—urinary bladder cancer	0.000612	0.00636	CbGeAlD
Cyclosporine—SLCO1B1—renal system—urinary bladder cancer	0.000571	0.00593	CbGeAlD
Cyclosporine—ABCC1—prostate gland—urinary bladder cancer	0.000559	0.00581	CbGeAlD
Cyclosporine—ABCC3—renal system—urinary bladder cancer	0.000541	0.00563	CbGeAlD
Cyclosporine—ABCC10—renal system—urinary bladder cancer	0.000539	0.0056	CbGeAlD
Cyclosporine—FKBP1A—female reproductive system—urinary bladder cancer	0.000539	0.0056	CbGeAlD
Cyclosporine—ABCC10—urethra—urinary bladder cancer	0.000529	0.0055	CbGeAlD
Cyclosporine—PPIF—lymph node—urinary bladder cancer	0.000495	0.00515	CbGeAlD
Cyclosporine—FKBP1A—vagina—urinary bladder cancer	0.000487	0.00506	CbGeAlD
Cyclosporine—PPP3CA—lymph node—urinary bladder cancer	0.000474	0.00493	CbGeAlD
Cyclosporine—ABCC1—seminal vesicle—urinary bladder cancer	0.000473	0.00492	CbGeAlD
Cyclosporine—PPIB—lymph node—urinary bladder cancer	0.000471	0.0049	CbGeAlD
Cyclosporine—SLCO1A2—renal system—urinary bladder cancer	0.000464	0.00483	CbGeAlD
Cyclosporine—ABCG2—prostate gland—urinary bladder cancer	0.000463	0.00481	CbGeAlD
Cyclosporine—SLCO1B1—female reproductive system—urinary bladder cancer	0.000457	0.00475	CbGeAlD
Cyclosporine—ABCC3—female reproductive system—urinary bladder cancer	0.000434	0.00451	CbGeAlD
Cyclosporine—ABCC2—renal system—urinary bladder cancer	0.000433	0.0045	CbGeAlD
Cyclosporine—ABCC10—female reproductive system—urinary bladder cancer	0.000431	0.00449	CbGeAlD
Cyclosporine—CYP3A5—prostate gland—urinary bladder cancer	0.00043	0.00447	CbGeAlD
Cyclosporine—ABCG2—seminal vesicle—urinary bladder cancer	0.000391	0.00407	CbGeAlD
Cyclosporine—ABCC10—vagina—urinary bladder cancer	0.00039	0.00406	CbGeAlD
Cyclosporine—ABCC1—urethra—urinary bladder cancer	0.000374	0.00389	CbGeAlD
Cyclosporine—ABCC2—female reproductive system—urinary bladder cancer	0.000346	0.0036	CbGeAlD
Cyclosporine—CYP2C8—renal system—urinary bladder cancer	0.000324	0.00337	CbGeAlD
Cyclosporine—FKBP1A—lymph node—urinary bladder cancer	0.000315	0.00328	CbGeAlD
Cyclosporine—ABCG2—urethra—urinary bladder cancer	0.00031	0.00322	CbGeAlD
Cyclosporine—CYP3A5—renal system—urinary bladder cancer	0.000293	0.00304	CbGeAlD
Cyclosporine—ABCC1—vagina—urinary bladder cancer	0.000276	0.00287	CbGeAlD
Cyclosporine—CYP2C19—vagina—urinary bladder cancer	0.000269	0.0028	CbGeAlD
Cyclosporine—CYP2C8—female reproductive system—urinary bladder cancer	0.00026	0.0027	CbGeAlD
Cyclosporine—ABCC3—lymph node—urinary bladder cancer	0.000254	0.00264	CbGeAlD
Cyclosporine—ABCC10—lymph node—urinary bladder cancer	0.000252	0.00262	CbGeAlD
Cyclosporine—CYP2C8—vagina—urinary bladder cancer	0.000235	0.00244	CbGeAlD
Cyclosporine—CYP2C9—female reproductive system—urinary bladder cancer	0.000231	0.0024	CbGeAlD
Cyclosporine—ABCG2—vagina—urinary bladder cancer	0.000229	0.00238	CbGeAlD
Cyclosporine—ABCB1—prostate gland—urinary bladder cancer	0.000228	0.00237	CbGeAlD
Cyclosporine—CYP3A4—renal system—urinary bladder cancer	0.00022	0.00229	CbGeAlD
Cyclosporine—CYP2D6—renal system—urinary bladder cancer	0.000216	0.00225	CbGeAlD
Cyclosporine—CYP3A5—vagina—urinary bladder cancer	0.000212	0.00221	CbGeAlD
Cyclosporine—ABCC2—lymph node—urinary bladder cancer	0.000203	0.00211	CbGeAlD
Cyclosporine—ABCB1—seminal vesicle—urinary bladder cancer	0.000193	0.00201	CbGeAlD
Cyclosporine—ABCC1—lymph node—urinary bladder cancer	0.000179	0.00186	CbGeAlD
Cyclosporine—CYP3A4—female reproductive system—urinary bladder cancer	0.000176	0.00183	CbGeAlD
Cyclosporine—CYP2D6—female reproductive system—urinary bladder cancer	0.000173	0.0018	CbGeAlD
Cyclosporine—ABCB1—epithelium—urinary bladder cancer	0.000168	0.00174	CbGeAlD
Cyclosporine—ABCB1—renal system—urinary bladder cancer	0.000156	0.00162	CbGeAlD
Cyclosporine—ABCB1—urethra—urinary bladder cancer	0.000153	0.00159	CbGeAlD
Cyclosporine—ABCG2—lymph node—urinary bladder cancer	0.000148	0.00154	CbGeAlD
Cyclosporine—ABCB1—female reproductive system—urinary bladder cancer	0.000125	0.0013	CbGeAlD
Cyclosporine—ABCB1—vagina—urinary bladder cancer	0.000113	0.00117	CbGeAlD
Cyclosporine—ABCB1—lymph node—urinary bladder cancer	7.29e-05	0.000758	CbGeAlD
Cyclosporine—Visual impairment—Methotrexate—urinary bladder cancer	5.74e-05	0.000311	CcSEcCtD
Cyclosporine—Hypersensitivity—Cisplatin—urinary bladder cancer	5.68e-05	0.000308	CcSEcCtD
Cyclosporine—Diarrhoea—Gemcitabine—urinary bladder cancer	5.66e-05	0.000307	CcSEcCtD
Cyclosporine—Renal failure—Doxorubicin—urinary bladder cancer	5.65e-05	0.000306	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	5.63e-05	0.000305	CcSEcCtD
Cyclosporine—Urticaria—Etoposide—urinary bladder cancer	5.61e-05	0.000304	CcSEcCtD
Cyclosporine—Haemoglobin—Epirubicin—urinary bladder cancer	5.6e-05	0.000304	CcSEcCtD
Cyclosporine—Stomatitis—Doxorubicin—urinary bladder cancer	5.6e-05	0.000304	CcSEcCtD
Cyclosporine—Jaundice—Doxorubicin—urinary bladder cancer	5.6e-05	0.000304	CcSEcCtD
Cyclosporine—Rhinitis—Epirubicin—urinary bladder cancer	5.59e-05	0.000303	CcSEcCtD
Cyclosporine—Abdominal pain—Etoposide—urinary bladder cancer	5.58e-05	0.000303	CcSEcCtD
Cyclosporine—Body temperature increased—Etoposide—urinary bladder cancer	5.58e-05	0.000303	CcSEcCtD
Cyclosporine—Conjunctivitis—Doxorubicin—urinary bladder cancer	5.58e-05	0.000303	CcSEcCtD
Cyclosporine—Urinary tract infection—Doxorubicin—urinary bladder cancer	5.58e-05	0.000303	CcSEcCtD
Cyclosporine—Haemorrhage—Epirubicin—urinary bladder cancer	5.57e-05	0.000302	CcSEcCtD
Cyclosporine—Hepatitis—Epirubicin—urinary bladder cancer	5.57e-05	0.000302	CcSEcCtD
Cyclosporine—Diarrhoea—Fluorouracil—urinary bladder cancer	5.56e-05	0.000302	CcSEcCtD
Cyclosporine—Tinnitus—Methotrexate—urinary bladder cancer	5.55e-05	0.000301	CcSEcCtD
Cyclosporine—Hypoaesthesia—Epirubicin—urinary bladder cancer	5.54e-05	0.000301	CcSEcCtD
Cyclosporine—Asthenia—Cisplatin—urinary bladder cancer	5.53e-05	0.0003	CcSEcCtD
Cyclosporine—Pharyngitis—Epirubicin—urinary bladder cancer	5.53e-05	0.0003	CcSEcCtD
Cyclosporine—Urinary tract disorder—Epirubicin—urinary bladder cancer	5.5e-05	0.000298	CcSEcCtD
Cyclosporine—Haematuria—Doxorubicin—urinary bladder cancer	5.48e-05	0.000297	CcSEcCtD
Cyclosporine—Connective tissue disorder—Epirubicin—urinary bladder cancer	5.48e-05	0.000297	CcSEcCtD
Cyclosporine—Urethral disorder—Epirubicin—urinary bladder cancer	5.46e-05	0.000296	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	5.43e-05	0.000295	CcSEcCtD
Cyclosporine—Epistaxis—Doxorubicin—urinary bladder cancer	5.42e-05	0.000294	CcSEcCtD
Cyclosporine—Angiopathy—Methotrexate—urinary bladder cancer	5.4e-05	0.000293	CcSEcCtD
Cyclosporine—Sinusitis—Doxorubicin—urinary bladder cancer	5.39e-05	0.000292	CcSEcCtD
Cyclosporine—Dizziness—Fluorouracil—urinary bladder cancer	5.38e-05	0.000292	CcSEcCtD
Cyclosporine—Visual impairment—Epirubicin—urinary bladder cancer	5.37e-05	0.000291	CcSEcCtD
Cyclosporine—Mediastinal disorder—Methotrexate—urinary bladder cancer	5.37e-05	0.000291	CcSEcCtD
Cyclosporine—Chills—Methotrexate—urinary bladder cancer	5.34e-05	0.00029	CcSEcCtD
Cyclosporine—Diarrhoea—Cisplatin—urinary bladder cancer	5.27e-05	0.000286	CcSEcCtD
Cyclosporine—Alopecia—Methotrexate—urinary bladder cancer	5.26e-05	0.000285	CcSEcCtD
Cyclosporine—Vomiting—Gemcitabine—urinary bladder cancer	5.26e-05	0.000285	CcSEcCtD
Cyclosporine—Mental disorder—Methotrexate—urinary bladder cancer	5.22e-05	0.000283	CcSEcCtD
Cyclosporine—Rash—Gemcitabine—urinary bladder cancer	5.21e-05	0.000283	CcSEcCtD
Cyclosporine—Dermatitis—Gemcitabine—urinary bladder cancer	5.21e-05	0.000283	CcSEcCtD
Cyclosporine—Hypersensitivity—Etoposide—urinary bladder cancer	5.2e-05	0.000282	CcSEcCtD
Cyclosporine—Tinnitus—Epirubicin—urinary bladder cancer	5.2e-05	0.000282	CcSEcCtD
Cyclosporine—Malnutrition—Methotrexate—urinary bladder cancer	5.18e-05	0.000281	CcSEcCtD
Cyclosporine—Haemoglobin—Doxorubicin—urinary bladder cancer	5.18e-05	0.000281	CcSEcCtD
Cyclosporine—Headache—Gemcitabine—urinary bladder cancer	5.18e-05	0.000281	CcSEcCtD
Cyclosporine—Flushing—Epirubicin—urinary bladder cancer	5.17e-05	0.000281	CcSEcCtD
Cyclosporine—Vomiting—Fluorouracil—urinary bladder cancer	5.17e-05	0.00028	CcSEcCtD
Cyclosporine—Rhinitis—Doxorubicin—urinary bladder cancer	5.17e-05	0.00028	CcSEcCtD
Cyclosporine—Haemorrhage—Doxorubicin—urinary bladder cancer	5.16e-05	0.00028	CcSEcCtD
Cyclosporine—Hepatitis—Doxorubicin—urinary bladder cancer	5.16e-05	0.00028	CcSEcCtD
Cyclosporine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	5.13e-05	0.000278	CcSEcCtD
Cyclosporine—Rash—Fluorouracil—urinary bladder cancer	5.13e-05	0.000278	CcSEcCtD
Cyclosporine—Dermatitis—Fluorouracil—urinary bladder cancer	5.12e-05	0.000278	CcSEcCtD
Cyclosporine—Pharyngitis—Doxorubicin—urinary bladder cancer	5.12e-05	0.000278	CcSEcCtD
Cyclosporine—Headache—Fluorouracil—urinary bladder cancer	5.09e-05	0.000276	CcSEcCtD
Cyclosporine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	5.09e-05	0.000276	CcSEcCtD
Cyclosporine—Dysgeusia—Methotrexate—urinary bladder cancer	5.08e-05	0.000275	CcSEcCtD
Cyclosporine—Asthenia—Etoposide—urinary bladder cancer	5.07e-05	0.000275	CcSEcCtD
Cyclosporine—Connective tissue disorder—Doxorubicin—urinary bladder cancer	5.07e-05	0.000275	CcSEcCtD
Cyclosporine—Angiopathy—Epirubicin—urinary bladder cancer	5.06e-05	0.000274	CcSEcCtD
Cyclosporine—Urethral disorder—Doxorubicin—urinary bladder cancer	5.05e-05	0.000274	CcSEcCtD
Cyclosporine—Mediastinal disorder—Epirubicin—urinary bladder cancer	5.02e-05	0.000272	CcSEcCtD
Cyclosporine—Chills—Epirubicin—urinary bladder cancer	5e-05	0.000271	CcSEcCtD
Cyclosporine—Pruritus—Etoposide—urinary bladder cancer	5e-05	0.000271	CcSEcCtD
Cyclosporine—Arrhythmia—Epirubicin—urinary bladder cancer	4.98e-05	0.00027	CcSEcCtD
Cyclosporine—Visual impairment—Doxorubicin—urinary bladder cancer	4.97e-05	0.00027	CcSEcCtD
Cyclosporine—Alopecia—Epirubicin—urinary bladder cancer	4.92e-05	0.000267	CcSEcCtD
Cyclosporine—Nausea—Gemcitabine—urinary bladder cancer	4.91e-05	0.000266	CcSEcCtD
Cyclosporine—Vomiting—Cisplatin—urinary bladder cancer	4.9e-05	0.000266	CcSEcCtD
Cyclosporine—Vision blurred—Methotrexate—urinary bladder cancer	4.89e-05	0.000265	CcSEcCtD
Cyclosporine—Mental disorder—Epirubicin—urinary bladder cancer	4.88e-05	0.000265	CcSEcCtD
Cyclosporine—Rash—Cisplatin—urinary bladder cancer	4.86e-05	0.000264	CcSEcCtD
Cyclosporine—Dermatitis—Cisplatin—urinary bladder cancer	4.86e-05	0.000263	CcSEcCtD
Cyclosporine—Malnutrition—Epirubicin—urinary bladder cancer	4.85e-05	0.000263	CcSEcCtD
Cyclosporine—Diarrhoea—Etoposide—urinary bladder cancer	4.83e-05	0.000262	CcSEcCtD
Cyclosporine—Nausea—Fluorouracil—urinary bladder cancer	4.83e-05	0.000262	CcSEcCtD
Cyclosporine—Ill-defined disorder—Methotrexate—urinary bladder cancer	4.81e-05	0.000261	CcSEcCtD
Cyclosporine—Tinnitus—Doxorubicin—urinary bladder cancer	4.81e-05	0.000261	CcSEcCtD
Cyclosporine—Anaemia—Methotrexate—urinary bladder cancer	4.79e-05	0.00026	CcSEcCtD
Cyclosporine—Flushing—Doxorubicin—urinary bladder cancer	4.79e-05	0.00026	CcSEcCtD
Cyclosporine—Flatulence—Epirubicin—urinary bladder cancer	4.78e-05	0.000259	CcSEcCtD
Cyclosporine—Tension—Epirubicin—urinary bladder cancer	4.76e-05	0.000258	CcSEcCtD
Cyclosporine—Dysgeusia—Epirubicin—urinary bladder cancer	4.75e-05	0.000258	CcSEcCtD
Cyclosporine—Nervousness—Epirubicin—urinary bladder cancer	4.71e-05	0.000256	CcSEcCtD
Cyclosporine—Angiopathy—Doxorubicin—urinary bladder cancer	4.68e-05	0.000254	CcSEcCtD
Cyclosporine—Malaise—Methotrexate—urinary bladder cancer	4.67e-05	0.000254	CcSEcCtD
Cyclosporine—Dizziness—Etoposide—urinary bladder cancer	4.67e-05	0.000253	CcSEcCtD
Cyclosporine—Muscle spasms—Epirubicin—urinary bladder cancer	4.66e-05	0.000253	CcSEcCtD
Cyclosporine—Vertigo—Methotrexate—urinary bladder cancer	4.66e-05	0.000253	CcSEcCtD
Cyclosporine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	4.65e-05	0.000252	CcSEcCtD
Cyclosporine—Leukopenia—Methotrexate—urinary bladder cancer	4.64e-05	0.000252	CcSEcCtD
Cyclosporine—Chills—Doxorubicin—urinary bladder cancer	4.63e-05	0.000251	CcSEcCtD
Cyclosporine—Arrhythmia—Doxorubicin—urinary bladder cancer	4.61e-05	0.00025	CcSEcCtD
Cyclosporine—Nausea—Cisplatin—urinary bladder cancer	4.58e-05	0.000248	CcSEcCtD
Cyclosporine—Vision blurred—Epirubicin—urinary bladder cancer	4.57e-05	0.000248	CcSEcCtD
Cyclosporine—Alopecia—Doxorubicin—urinary bladder cancer	4.56e-05	0.000247	CcSEcCtD
Cyclosporine—Cough—Methotrexate—urinary bladder cancer	4.52e-05	0.000245	CcSEcCtD
Cyclosporine—Mental disorder—Doxorubicin—urinary bladder cancer	4.52e-05	0.000245	CcSEcCtD
Cyclosporine—Ill-defined disorder—Epirubicin—urinary bladder cancer	4.5e-05	0.000244	CcSEcCtD
Cyclosporine—Convulsion—Methotrexate—urinary bladder cancer	4.49e-05	0.000244	CcSEcCtD
Cyclosporine—Vomiting—Etoposide—urinary bladder cancer	4.49e-05	0.000244	CcSEcCtD
Cyclosporine—Malnutrition—Doxorubicin—urinary bladder cancer	4.49e-05	0.000243	CcSEcCtD
Cyclosporine—Anaemia—Epirubicin—urinary bladder cancer	4.48e-05	0.000243	CcSEcCtD
Cyclosporine—Agitation—Epirubicin—urinary bladder cancer	4.46e-05	0.000242	CcSEcCtD
Cyclosporine—Rash—Etoposide—urinary bladder cancer	4.45e-05	0.000242	CcSEcCtD
Cyclosporine—Dermatitis—Etoposide—urinary bladder cancer	4.45e-05	0.000241	CcSEcCtD
Cyclosporine—Headache—Etoposide—urinary bladder cancer	4.42e-05	0.00024	CcSEcCtD
Cyclosporine—Flatulence—Doxorubicin—urinary bladder cancer	4.42e-05	0.00024	CcSEcCtD
Cyclosporine—Arthralgia—Methotrexate—urinary bladder cancer	4.41e-05	0.000239	CcSEcCtD
Cyclosporine—Chest pain—Methotrexate—urinary bladder cancer	4.41e-05	0.000239	CcSEcCtD
Cyclosporine—Myalgia—Methotrexate—urinary bladder cancer	4.41e-05	0.000239	CcSEcCtD
Cyclosporine—Tension—Doxorubicin—urinary bladder cancer	4.4e-05	0.000239	CcSEcCtD
Cyclosporine—Dysgeusia—Doxorubicin—urinary bladder cancer	4.4e-05	0.000238	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	4.38e-05	0.000238	CcSEcCtD
Cyclosporine—Malaise—Epirubicin—urinary bladder cancer	4.37e-05	0.000237	CcSEcCtD
Cyclosporine—Discomfort—Methotrexate—urinary bladder cancer	4.36e-05	0.000236	CcSEcCtD
Cyclosporine—Nervousness—Doxorubicin—urinary bladder cancer	4.36e-05	0.000236	CcSEcCtD
Cyclosporine—Vertigo—Epirubicin—urinary bladder cancer	4.36e-05	0.000236	CcSEcCtD
Cyclosporine—Leukopenia—Epirubicin—urinary bladder cancer	4.34e-05	0.000236	CcSEcCtD
Cyclosporine—Muscle spasms—Doxorubicin—urinary bladder cancer	4.32e-05	0.000234	CcSEcCtD
Cyclosporine—Confusional state—Methotrexate—urinary bladder cancer	4.27e-05	0.000231	CcSEcCtD
Cyclosporine—Cough—Epirubicin—urinary bladder cancer	4.23e-05	0.00023	CcSEcCtD
Cyclosporine—Anaphylactic shock—Methotrexate—urinary bladder cancer	4.23e-05	0.000229	CcSEcCtD
Cyclosporine—Vision blurred—Doxorubicin—urinary bladder cancer	4.23e-05	0.000229	CcSEcCtD
Cyclosporine—Convulsion—Epirubicin—urinary bladder cancer	4.2e-05	0.000228	CcSEcCtD
Cyclosporine—Infection—Methotrexate—urinary bladder cancer	4.2e-05	0.000228	CcSEcCtD
Cyclosporine—Nausea—Etoposide—urinary bladder cancer	4.2e-05	0.000228	CcSEcCtD
Cyclosporine—Hypertension—Epirubicin—urinary bladder cancer	4.19e-05	0.000227	CcSEcCtD
Cyclosporine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	4.16e-05	0.000226	CcSEcCtD
Cyclosporine—Nervous system disorder—Methotrexate—urinary bladder cancer	4.15e-05	0.000225	CcSEcCtD
Cyclosporine—Anaemia—Doxorubicin—urinary bladder cancer	4.15e-05	0.000225	CcSEcCtD
Cyclosporine—Thrombocytopenia—Methotrexate—urinary bladder cancer	4.14e-05	0.000225	CcSEcCtD
Cyclosporine—Arthralgia—Epirubicin—urinary bladder cancer	4.13e-05	0.000224	CcSEcCtD
Cyclosporine—Myalgia—Epirubicin—urinary bladder cancer	4.13e-05	0.000224	CcSEcCtD
Cyclosporine—Chest pain—Epirubicin—urinary bladder cancer	4.13e-05	0.000224	CcSEcCtD
Cyclosporine—Agitation—Doxorubicin—urinary bladder cancer	4.12e-05	0.000224	CcSEcCtD
Cyclosporine—Anxiety—Epirubicin—urinary bladder cancer	4.12e-05	0.000223	CcSEcCtD
Cyclosporine—Skin disorder—Methotrexate—urinary bladder cancer	4.11e-05	0.000223	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	4.1e-05	0.000222	CcSEcCtD
Cyclosporine—Hyperhidrosis—Methotrexate—urinary bladder cancer	4.09e-05	0.000222	CcSEcCtD
Cyclosporine—Discomfort—Epirubicin—urinary bladder cancer	4.08e-05	0.000221	CcSEcCtD
Cyclosporine—Malaise—Doxorubicin—urinary bladder cancer	4.05e-05	0.00022	CcSEcCtD
Cyclosporine—Dry mouth—Epirubicin—urinary bladder cancer	4.04e-05	0.000219	CcSEcCtD
Cyclosporine—Vertigo—Doxorubicin—urinary bladder cancer	4.03e-05	0.000219	CcSEcCtD
Cyclosporine—Anorexia—Methotrexate—urinary bladder cancer	4.03e-05	0.000219	CcSEcCtD
Cyclosporine—Leukopenia—Doxorubicin—urinary bladder cancer	4.02e-05	0.000218	CcSEcCtD
Cyclosporine—Confusional state—Epirubicin—urinary bladder cancer	3.99e-05	0.000217	CcSEcCtD
Cyclosporine—Anaphylactic shock—Epirubicin—urinary bladder cancer	3.96e-05	0.000215	CcSEcCtD
Cyclosporine—Oedema—Epirubicin—urinary bladder cancer	3.96e-05	0.000215	CcSEcCtD
Cyclosporine—Infection—Epirubicin—urinary bladder cancer	3.93e-05	0.000213	CcSEcCtD
Cyclosporine—Cough—Doxorubicin—urinary bladder cancer	3.92e-05	0.000212	CcSEcCtD
Cyclosporine—Convulsion—Doxorubicin—urinary bladder cancer	3.89e-05	0.000211	CcSEcCtD
Cyclosporine—Nervous system disorder—Epirubicin—urinary bladder cancer	3.88e-05	0.000211	CcSEcCtD
Cyclosporine—Thrombocytopenia—Epirubicin—urinary bladder cancer	3.88e-05	0.00021	CcSEcCtD
Cyclosporine—Hypertension—Doxorubicin—urinary bladder cancer	3.88e-05	0.00021	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	3.85e-05	0.000209	CcSEcCtD
Cyclosporine—Skin disorder—Epirubicin—urinary bladder cancer	3.85e-05	0.000209	CcSEcCtD
Cyclosporine—Hyperhidrosis—Epirubicin—urinary bladder cancer	3.83e-05	0.000208	CcSEcCtD
Cyclosporine—Insomnia—Methotrexate—urinary bladder cancer	3.83e-05	0.000208	CcSEcCtD
Cyclosporine—Chest pain—Doxorubicin—urinary bladder cancer	3.82e-05	0.000207	CcSEcCtD
Cyclosporine—Myalgia—Doxorubicin—urinary bladder cancer	3.82e-05	0.000207	CcSEcCtD
Cyclosporine—Arthralgia—Doxorubicin—urinary bladder cancer	3.82e-05	0.000207	CcSEcCtD
Cyclosporine—Anxiety—Doxorubicin—urinary bladder cancer	3.81e-05	0.000207	CcSEcCtD
Cyclosporine—Paraesthesia—Methotrexate—urinary bladder cancer	3.8e-05	0.000206	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	3.79e-05	0.000206	CcSEcCtD
Cyclosporine—Discomfort—Doxorubicin—urinary bladder cancer	3.78e-05	0.000205	CcSEcCtD
Cyclosporine—Anorexia—Epirubicin—urinary bladder cancer	3.77e-05	0.000205	CcSEcCtD
Cyclosporine—Dyspnoea—Methotrexate—urinary bladder cancer	3.77e-05	0.000205	CcSEcCtD
Cyclosporine—Somnolence—Methotrexate—urinary bladder cancer	3.76e-05	0.000204	CcSEcCtD
Cyclosporine—Dry mouth—Doxorubicin—urinary bladder cancer	3.74e-05	0.000203	CcSEcCtD
Cyclosporine—Dyspepsia—Methotrexate—urinary bladder cancer	3.72e-05	0.000202	CcSEcCtD
Cyclosporine—Confusional state—Doxorubicin—urinary bladder cancer	3.69e-05	0.0002	CcSEcCtD
Cyclosporine—Decreased appetite—Methotrexate—urinary bladder cancer	3.68e-05	0.000199	CcSEcCtD
Cyclosporine—Oedema—Doxorubicin—urinary bladder cancer	3.66e-05	0.000199	CcSEcCtD
Cyclosporine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	3.66e-05	0.000199	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	3.65e-05	0.000198	CcSEcCtD
Cyclosporine—Fatigue—Methotrexate—urinary bladder cancer	3.65e-05	0.000198	CcSEcCtD
Cyclosporine—Infection—Doxorubicin—urinary bladder cancer	3.64e-05	0.000197	CcSEcCtD
Cyclosporine—Pain—Methotrexate—urinary bladder cancer	3.62e-05	0.000196	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	3.61e-05	0.000196	CcSEcCtD
Cyclosporine—Nervous system disorder—Doxorubicin—urinary bladder cancer	3.59e-05	0.000195	CcSEcCtD
Cyclosporine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	3.59e-05	0.000195	CcSEcCtD
Cyclosporine—Insomnia—Epirubicin—urinary bladder cancer	3.58e-05	0.000194	CcSEcCtD
Cyclosporine—Skin disorder—Doxorubicin—urinary bladder cancer	3.56e-05	0.000193	CcSEcCtD
Cyclosporine—Paraesthesia—Epirubicin—urinary bladder cancer	3.55e-05	0.000193	CcSEcCtD
Cyclosporine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	3.54e-05	0.000192	CcSEcCtD
Cyclosporine—Dyspnoea—Epirubicin—urinary bladder cancer	3.53e-05	0.000191	CcSEcCtD
Cyclosporine—Somnolence—Epirubicin—urinary bladder cancer	3.52e-05	0.000191	CcSEcCtD
Cyclosporine—Anorexia—Doxorubicin—urinary bladder cancer	3.49e-05	0.000189	CcSEcCtD
Cyclosporine—Feeling abnormal—Methotrexate—urinary bladder cancer	3.49e-05	0.000189	CcSEcCtD
Cyclosporine—Dyspepsia—Epirubicin—urinary bladder cancer	3.48e-05	0.000189	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	3.46e-05	0.000188	CcSEcCtD
Cyclosporine—Decreased appetite—Epirubicin—urinary bladder cancer	3.44e-05	0.000187	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	3.42e-05	0.000185	CcSEcCtD
Cyclosporine—Fatigue—Epirubicin—urinary bladder cancer	3.41e-05	0.000185	CcSEcCtD
Cyclosporine—Pain—Epirubicin—urinary bladder cancer	3.39e-05	0.000184	CcSEcCtD
Cyclosporine—Constipation—Epirubicin—urinary bladder cancer	3.39e-05	0.000184	CcSEcCtD
Cyclosporine—Urticaria—Methotrexate—urinary bladder cancer	3.36e-05	0.000182	CcSEcCtD
Cyclosporine—Body temperature increased—Methotrexate—urinary bladder cancer	3.34e-05	0.000181	CcSEcCtD
Cyclosporine—Abdominal pain—Methotrexate—urinary bladder cancer	3.34e-05	0.000181	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	3.34e-05	0.000181	CcSEcCtD
Cyclosporine—Insomnia—Doxorubicin—urinary bladder cancer	3.31e-05	0.00018	CcSEcCtD
Cyclosporine—Paraesthesia—Doxorubicin—urinary bladder cancer	3.29e-05	0.000178	CcSEcCtD
Cyclosporine—Dyspnoea—Doxorubicin—urinary bladder cancer	3.27e-05	0.000177	CcSEcCtD
Cyclosporine—Feeling abnormal—Epirubicin—urinary bladder cancer	3.26e-05	0.000177	CcSEcCtD
Cyclosporine—Somnolence—Doxorubicin—urinary bladder cancer	3.26e-05	0.000177	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	3.24e-05	0.000176	CcSEcCtD
Cyclosporine—Dyspepsia—Doxorubicin—urinary bladder cancer	3.22e-05	0.000175	CcSEcCtD
Cyclosporine—Decreased appetite—Doxorubicin—urinary bladder cancer	3.18e-05	0.000173	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	3.16e-05	0.000172	CcSEcCtD
Cyclosporine—Fatigue—Doxorubicin—urinary bladder cancer	3.16e-05	0.000171	CcSEcCtD
Cyclosporine—Urticaria—Epirubicin—urinary bladder cancer	3.15e-05	0.000171	CcSEcCtD
Cyclosporine—Constipation—Doxorubicin—urinary bladder cancer	3.13e-05	0.00017	CcSEcCtD
Cyclosporine—Pain—Doxorubicin—urinary bladder cancer	3.13e-05	0.00017	CcSEcCtD
Cyclosporine—Abdominal pain—Epirubicin—urinary bladder cancer	3.13e-05	0.00017	CcSEcCtD
Cyclosporine—Body temperature increased—Epirubicin—urinary bladder cancer	3.13e-05	0.00017	CcSEcCtD
Cyclosporine—Hypersensitivity—Methotrexate—urinary bladder cancer	3.12e-05	0.000169	CcSEcCtD
Cyclosporine—Asthenia—Methotrexate—urinary bladder cancer	3.04e-05	0.000165	CcSEcCtD
Cyclosporine—Feeling abnormal—Doxorubicin—urinary bladder cancer	3.02e-05	0.000164	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	3e-05	0.000162	CcSEcCtD
Cyclosporine—Pruritus—Methotrexate—urinary bladder cancer	2.99e-05	0.000162	CcSEcCtD
Cyclosporine—Hypersensitivity—Epirubicin—urinary bladder cancer	2.92e-05	0.000158	CcSEcCtD
Cyclosporine—Urticaria—Doxorubicin—urinary bladder cancer	2.91e-05	0.000158	CcSEcCtD
Cyclosporine—Abdominal pain—Doxorubicin—urinary bladder cancer	2.9e-05	0.000157	CcSEcCtD
Cyclosporine—Body temperature increased—Doxorubicin—urinary bladder cancer	2.9e-05	0.000157	CcSEcCtD
Cyclosporine—Diarrhoea—Methotrexate—urinary bladder cancer	2.89e-05	0.000157	CcSEcCtD
Cyclosporine—Asthenia—Epirubicin—urinary bladder cancer	2.84e-05	0.000154	CcSEcCtD
Cyclosporine—Pruritus—Epirubicin—urinary bladder cancer	2.8e-05	0.000152	CcSEcCtD
Cyclosporine—Dizziness—Methotrexate—urinary bladder cancer	2.8e-05	0.000152	CcSEcCtD
Cyclosporine—Diarrhoea—Epirubicin—urinary bladder cancer	2.71e-05	0.000147	CcSEcCtD
Cyclosporine—Hypersensitivity—Doxorubicin—urinary bladder cancer	2.7e-05	0.000146	CcSEcCtD
Cyclosporine—Vomiting—Methotrexate—urinary bladder cancer	2.69e-05	0.000146	CcSEcCtD
Cyclosporine—Rash—Methotrexate—urinary bladder cancer	2.67e-05	0.000145	CcSEcCtD
Cyclosporine—Dermatitis—Methotrexate—urinary bladder cancer	2.66e-05	0.000145	CcSEcCtD
Cyclosporine—Headache—Methotrexate—urinary bladder cancer	2.65e-05	0.000144	CcSEcCtD
Cyclosporine—Asthenia—Doxorubicin—urinary bladder cancer	2.63e-05	0.000143	CcSEcCtD
Cyclosporine—Dizziness—Epirubicin—urinary bladder cancer	2.62e-05	0.000142	CcSEcCtD
Cyclosporine—Pruritus—Doxorubicin—urinary bladder cancer	2.59e-05	0.000141	CcSEcCtD
Cyclosporine—Vomiting—Epirubicin—urinary bladder cancer	2.52e-05	0.000137	CcSEcCtD
Cyclosporine—Nausea—Methotrexate—urinary bladder cancer	2.51e-05	0.000136	CcSEcCtD
Cyclosporine—Diarrhoea—Doxorubicin—urinary bladder cancer	2.51e-05	0.000136	CcSEcCtD
Cyclosporine—Rash—Epirubicin—urinary bladder cancer	2.5e-05	0.000135	CcSEcCtD
Cyclosporine—Dermatitis—Epirubicin—urinary bladder cancer	2.49e-05	0.000135	CcSEcCtD
Cyclosporine—Headache—Epirubicin—urinary bladder cancer	2.48e-05	0.000135	CcSEcCtD
Cyclosporine—Dizziness—Doxorubicin—urinary bladder cancer	2.42e-05	0.000131	CcSEcCtD
Cyclosporine—Nausea—Epirubicin—urinary bladder cancer	2.35e-05	0.000128	CcSEcCtD
Cyclosporine—Vomiting—Doxorubicin—urinary bladder cancer	2.33e-05	0.000126	CcSEcCtD
Cyclosporine—Rash—Doxorubicin—urinary bladder cancer	2.31e-05	0.000125	CcSEcCtD
Cyclosporine—Dermatitis—Doxorubicin—urinary bladder cancer	2.31e-05	0.000125	CcSEcCtD
Cyclosporine—Headache—Doxorubicin—urinary bladder cancer	2.29e-05	0.000124	CcSEcCtD
Cyclosporine—Nausea—Doxorubicin—urinary bladder cancer	2.18e-05	0.000118	CcSEcCtD
Cyclosporine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	7.41e-06	6.13e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.38e-06	6.11e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—NCOR1—urinary bladder cancer	7.38e-06	6.11e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—GSTM1—urinary bladder cancer	7.38e-06	6.11e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	7.36e-06	6.1e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—TYMP—urinary bladder cancer	7.34e-06	6.08e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—EP300—urinary bladder cancer	7.33e-06	6.07e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	7.31e-06	6.05e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	7.3e-06	6.05e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	7.28e-06	6.03e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	7.25e-06	6e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	7.18e-06	5.95e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—HRAS—urinary bladder cancer	7.16e-06	5.93e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—SRC—urinary bladder cancer	7.13e-06	5.9e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	7.13e-06	5.9e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—FGFR3—urinary bladder cancer	7.13e-06	5.9e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—NAT2—urinary bladder cancer	7.11e-06	5.88e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	7.09e-06	5.87e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—MYC—urinary bladder cancer	7.07e-06	5.86e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—GPX1—urinary bladder cancer	7.07e-06	5.85e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—GSTP1—urinary bladder cancer	7.07e-06	5.85e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	7.05e-06	5.84e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—RRM2—urinary bladder cancer	7.04e-06	5.83e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PPARG—urinary bladder cancer	7.04e-06	5.83e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	7.01e-06	5.81e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	7.01e-06	5.81e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	7e-06	5.8e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—ERBB2—urinary bladder cancer	6.99e-06	5.79e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—ERCC2—urinary bladder cancer	6.94e-06	5.74e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—EGFR—urinary bladder cancer	6.92e-06	5.73e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—CREBBP—urinary bladder cancer	6.76e-06	5.6e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PPARG—urinary bladder cancer	6.75e-06	5.59e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	6.71e-06	5.56e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	6.7e-06	5.55e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—NAT2—urinary bladder cancer	6.64e-06	5.5e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CXCL8—urinary bladder cancer	6.63e-06	5.49e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	6.59e-06	5.46e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	6.58e-06	5.45e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—TYMS—urinary bladder cancer	6.57e-06	5.44e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—KRAS—urinary bladder cancer	6.54e-06	5.41e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	6.52e-06	5.4e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ENO2—urinary bladder cancer	6.52e-06	5.4e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—MTHFR—urinary bladder cancer	6.52e-06	5.4e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—TYMS—urinary bladder cancer	6.51e-06	5.39e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—GSTM1—urinary bladder cancer	6.49e-06	5.38e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—NCOR1—urinary bladder cancer	6.49e-06	5.38e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.48e-06	5.37e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—CREBBP—urinary bladder cancer	6.48e-06	5.37e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	6.44e-06	5.33e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	6.44e-06	5.33e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MYC—urinary bladder cancer	6.39e-06	5.29e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL2—urinary bladder cancer	6.33e-06	5.25e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	6.33e-06	5.24e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	6.33e-06	5.24e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	6.29e-06	5.2e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—EGFR—urinary bladder cancer	6.25e-06	5.17e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.23e-06	5.16e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—GPX1—urinary bladder cancer	6.22e-06	5.15e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	6.21e-06	5.15e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	6.2e-06	5.13e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCND1—urinary bladder cancer	6.17e-06	5.11e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—GPX1—urinary bladder cancer	6.16e-06	5.1e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—RRM2—urinary bladder cancer	6.13e-06	5.08e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—ERCC2—urinary bladder cancer	6.1e-06	5.05e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—NQO1—urinary bladder cancer	6.07e-06	5.03e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CREBBP—urinary bladder cancer	6.07e-06	5.02e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	6.06e-06	5.01e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	6.05e-06	5.01e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MMP9—urinary bladder cancer	5.99e-06	4.96e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CDKN1A—urinary bladder cancer	5.97e-06	4.95e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PTEN—urinary bladder cancer	5.96e-06	4.94e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—KRAS—urinary bladder cancer	5.9e-06	4.89e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	5.88e-06	4.87e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	5.82e-06	4.82e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	5.82e-06	4.82e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.79e-06	4.79e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	5.78e-06	4.79e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—MTHFR—urinary bladder cancer	5.74e-06	4.75e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—RRM2—urinary bladder cancer	5.73e-06	4.75e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	5.69e-06	4.71e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—EP300—urinary bladder cancer	5.68e-06	4.71e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	5.68e-06	4.7e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ENO2—urinary bladder cancer	5.68e-06	4.7e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	5.65e-06	4.68e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	5.64e-06	4.67e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.56e-06	4.6e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—HRAS—urinary bladder cancer	5.56e-06	4.6e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PTGS2—urinary bladder cancer	5.54e-06	4.58e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—SRC—urinary bladder cancer	5.53e-06	4.58e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	5.51e-06	4.56e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—RHOA—urinary bladder cancer	5.49e-06	4.54e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	5.35e-06	4.43e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	5.35e-06	4.43e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PTGS2—urinary bladder cancer	5.31e-06	4.4e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ENO2—urinary bladder cancer	5.31e-06	4.4e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	5.31e-06	4.4e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PPARG—urinary bladder cancer	5.29e-06	4.38e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.28e-06	4.37e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—NQO1—urinary bladder cancer	5.26e-06	4.35e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TP53—urinary bladder cancer	5.25e-06	4.34e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	5.19e-06	4.3e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.16e-06	4.27e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	5.15e-06	4.26e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.1e-06	4.22e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—CREBBP—urinary bladder cancer	5.08e-06	4.21e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—ERBB2—urinary bladder cancer	5.08e-06	4.21e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.07e-06	4.2e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	5.06e-06	4.19e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	5.02e-06	4.16e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—HRAS—urinary bladder cancer	5.02e-06	4.15e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PTGS2—urinary bladder cancer	4.97e-06	4.11e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MYC—urinary bladder cancer	4.95e-06	4.1e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—EGFR—urinary bladder cancer	4.84e-06	4.01e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	4.84e-06	4.01e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PTEN—urinary bladder cancer	4.83e-06	4e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	4.83e-06	4e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—TYMS—urinary bladder cancer	4.71e-06	3.9e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	4.69e-06	3.89e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PPARG—urinary bladder cancer	4.65e-06	3.85e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	4.65e-06	3.85e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	4.65e-06	3.85e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PTEN—urinary bladder cancer	4.63e-06	3.83e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	4.62e-06	3.83e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PPARG—urinary bladder cancer	4.61e-06	3.82e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—EP300—urinary bladder cancer	4.61e-06	3.81e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—NQO1—urinary bladder cancer	4.58e-06	3.79e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—KRAS—urinary bladder cancer	4.58e-06	3.79e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.55e-06	3.77e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—CREBBP—urinary bladder cancer	4.47e-06	3.7e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GPX1—urinary bladder cancer	4.45e-06	3.69e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.45e-06	3.68e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	4.43e-06	3.67e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—EP300—urinary bladder cancer	4.42e-06	3.66e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	4.38e-06	3.63e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	4.38e-06	3.63e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	4.37e-06	3.62e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CDKN1A—urinary bladder cancer	4.34e-06	3.59e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PTEN—urinary bladder cancer	4.33e-06	3.59e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	4.32e-06	3.57e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—NQO1—urinary bladder cancer	4.28e-06	3.54e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.24e-06	3.51e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PTGS2—urinary bladder cancer	4.16e-06	3.44e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.15e-06	3.44e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—EP300—urinary bladder cancer	4.13e-06	3.42e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	4.11e-06	3.4e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—TYMS—urinary bladder cancer	4.08e-06	3.38e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TP53—urinary bladder cancer	4.07e-06	3.37e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	4.03e-06	3.34e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	4.03e-06	3.34e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	4.03e-06	3.34e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—SRC—urinary bladder cancer	4.02e-06	3.33e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.97e-06	3.29e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	3.95e-06	3.27e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	3.91e-06	3.24e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—HRAS—urinary bladder cancer	3.89e-06	3.22e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GPX1—urinary bladder cancer	3.86e-06	3.19e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—EP300—urinary bladder cancer	3.84e-06	3.18e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	3.82e-06	3.16e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	3.79e-06	3.14e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.79e-06	3.14e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	3.78e-06	3.13e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PTGS2—urinary bladder cancer	3.66e-06	3.03e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	3.64e-06	3.01e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	3.63e-06	3e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PTEN—urinary bladder cancer	3.63e-06	3e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.62e-06	3e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MYC—urinary bladder cancer	3.6e-06	2.98e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	3.6e-06	2.98e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	3.6e-06	2.98e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	3.6e-06	2.98e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	3.57e-06	2.95e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	3.56e-06	2.95e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—TYMS—urinary bladder cancer	3.55e-06	2.94e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—EGFR—urinary bladder cancer	3.52e-06	2.92e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	3.51e-06	2.91e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	3.51e-06	2.91e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	3.5e-06	2.9e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	3.5e-06	2.9e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—EP300—urinary bladder cancer	3.46e-06	2.86e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.45e-06	2.86e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	3.45e-06	2.85e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	3.44e-06	2.85e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	3.4e-06	2.81e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	3.38e-06	2.8e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GPX1—urinary bladder cancer	3.36e-06	2.78e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	3.35e-06	2.77e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PPARG—urinary bladder cancer	3.33e-06	2.76e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—KRAS—urinary bladder cancer	3.33e-06	2.75e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—TYMS—urinary bladder cancer	3.32e-06	2.75e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	3.31e-06	2.74e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	3.31e-06	2.74e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	3.3e-06	2.73e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—EP300—urinary bladder cancer	3.29e-06	2.72e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	3.28e-06	2.72e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	3.28e-06	2.72e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	3.2e-06	2.65e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PTEN—urinary bladder cancer	3.19e-06	2.64e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	3.18e-06	2.63e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	3.17e-06	2.62e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PTEN—urinary bladder cancer	3.16e-06	2.62e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	3.14e-06	2.6e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	3.11e-06	2.58e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	3.1e-06	2.57e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	3.08e-06	2.55e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—EP300—urinary bladder cancer	3.04e-06	2.52e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—EP300—urinary bladder cancer	3.02e-06	2.5e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	2.92e-06	2.42e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	2.9e-06	2.4e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PPARG—urinary bladder cancer	2.89e-06	2.39e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—HRAS—urinary bladder cancer	2.83e-06	2.34e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.82e-06	2.34e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	2.77e-06	2.3e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	2.62e-06	2.17e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	2.58e-06	2.13e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PPARG—urinary bladder cancer	2.52e-06	2.08e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	2.48e-06	2.05e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	2.42e-06	2e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	2.37e-06	1.96e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.35e-06	1.95e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	2.35e-06	1.95e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	2.29e-06	1.89e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	2.28e-06	1.89e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	2.27e-06	1.88e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	2.26e-06	1.87e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	2.19e-06	1.81e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—EP300—urinary bladder cancer	2.18e-06	1.81e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	2.16e-06	1.79e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	2.16e-06	1.79e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	2.07e-06	1.71e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	2.03e-06	1.68e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	2.03e-06	1.68e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	1.98e-06	1.64e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.98e-06	1.64e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.91e-06	1.58e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—EP300—urinary bladder cancer	1.89e-06	1.56e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.86e-06	1.54e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.85e-06	1.53e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.77e-06	1.46e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.73e-06	1.43e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.69e-06	1.4e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—EP300—urinary bladder cancer	1.65e-06	1.36e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.63e-06	1.35e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.61e-06	1.33e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.55e-06	1.28e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.55e-06	1.28e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.54e-06	1.27e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.49e-06	1.23e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.22e-06	1.01e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.06e-06	8.8e-06	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.01e-06	8.4e-06	CbGpPWpGaD
